Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jierui Cai"'
Autor:
Anton Lahusen, Jierui Cai, Reinhold Schirmbeck, Anton Wellstein, Alexander Kleger, Thomas Seufferlein, Tim Eiseler, Yuan-Na Lin
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Poor treatment responses of pancreatic ductal adenocarcinoma (PDAC) are in large part due to tumor heterogeneity and an immunosuppressive desmoplastic tumor stroma that impacts interactions with cells in the tumor microenvironment (TME). Thu
Externí odkaz:
https://doaj.org/article/b0d5b32d19104b149b1be3d870bb0c11
Autor:
Jonathan Schönfelder, Tanja Seibold, Mareen Morawe, Robert Sroka, Nora Schneider, Jierui Cai, Josip Golomejic, Lena Schütte, Milena Armacki, Markus Huber-Lang, Miriam Kalbitz, Thomas Seufferlein, Tim Eiseler
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Trauma is a major cause of death worldwide. The post-traumatic immune response culminates in the release of pro-inflammatory mediators, translating in the infiltration of neutrophils (PMNs) at injury sites. The extent of this inflammation is determin
Externí odkaz:
https://doaj.org/article/c79b3984f7a240d8a78aa509466db241
Publikováno v:
Gastroenterology Research and Practice, Vol 2019 (2019)
Background. Crohn’s disease (CD) is a chronic intestinal inflammatory disease. An ideal laboratory marker that can predict the prognosis in terms of relapse of the disease is clinically desirable. Methods. A total of 59 CD patients were enrolled in
Externí odkaz:
https://doaj.org/article/6aaf801bcdf74a129a2490cf73796c51
Publikováno v:
Gastroenterology Research and Practice, Vol 2019 (2019)
Gastroenterology Research and Practice
Gastroenterology Research and Practice
Background. Crohn’s disease (CD) is a chronic intestinal inflammatory disease. An ideal laboratory marker that can predict the prognosis in terms of relapse of the disease is clinically desirable. Methods. A total of 59 CD patients were enrolled in